QualityStocksNewsBreaks – Cybin Corp. Focused on Advancing New Products Amid Positive Research in Psychedelics
Cybin Corp., an exemplary Canada-based, life-science company focused on the development of pharmaceutical-grade psilocybin products, is at the forefront of change in an era open to exploring psychedelic treatment options where big pharma has failed. Started in the 1940s, but kiboshed in the 1960s with President Richard Nixon’s war on drugs, researchers have once again picked up the study of psychedelics in the treatment of mental health conditions. Research is showing positive results for many indications and disorders including depression, anxiety, PTSD, addictions, ADHD and more. A recent article discussing this reads, “Cybin believes that psychedelic substances derived from mushrooms…